nodes	percent_of_prediction	percent_of_DWPC	metapath
Pomalidomide—TNF—pancreatitis	0.582	0.678	CbGaD
Pomalidomide—PTGS2—pancreatitis	0.277	0.322	CbGaD
Pomalidomide—Thalidomide—TNF—pancreatitis	0.00246	0.441	CrCbGaD
Pomalidomide—TNF—blood—pancreatitis	0.00237	0.186	CbGeAlD
Pomalidomide—CRBN—islet of Langerhans—pancreatitis	0.00198	0.156	CbGeAlD
Pomalidomide—Lenalidomide—PTGS2—pancreatitis	0.00195	0.35	CrCbGaD
Pomalidomide—Depressed level of consciousness—Hyoscyamine—pancreatitis	0.00155	0.0528	CcSEcCtD
Pomalidomide—CRBN—pancreas—pancreatitis	0.00139	0.109	CbGeAlD
Pomalidomide—Atrial fibrillation—Hyoscyamine—pancreatitis	0.00123	0.0419	CcSEcCtD
Pomalidomide—CRBN—digestive system—pancreatitis	0.00119	0.0935	CbGeAlD
Pomalidomide—Hyponatraemia—Hyoscyamine—pancreatitis	0.00117	0.0399	CcSEcCtD
Pomalidomide—Thalidomide—PTGS2—pancreatitis	0.00117	0.209	CrCbGaD
Pomalidomide—CRBN—blood—pancreatitis	0.00113	0.0891	CbGeAlD
Pomalidomide—Confusional state—Propantheline—pancreatitis	0.00113	0.0385	CcSEcCtD
Pomalidomide—Urinary retention—Hyoscyamine—pancreatitis	0.00111	0.0378	CcSEcCtD
Pomalidomide—Dehydration—Hyoscyamine—pancreatitis	0.00108	0.0369	CcSEcCtD
Pomalidomide—Dry skin—Hyoscyamine—pancreatitis	0.00107	0.0364	CcSEcCtD
Pomalidomide—Hypokalaemia—Hyoscyamine—pancreatitis	0.00106	0.0362	CcSEcCtD
Pomalidomide—Insomnia—Propantheline—pancreatitis	0.00101	0.0345	CcSEcCtD
Pomalidomide—Constipation—Propantheline—pancreatitis	0.000956	0.0326	CcSEcCtD
Pomalidomide—Feeling abnormal—Propantheline—pancreatitis	0.000921	0.0314	CcSEcCtD
Pomalidomide—Hyperglycaemia—Hyoscyamine—pancreatitis	0.000908	0.031	CcSEcCtD
Pomalidomide—PTGS2—gall bladder—pancreatitis	0.000824	0.0647	CbGeAlD
Pomalidomide—Hypersensitivity—Propantheline—pancreatitis	0.000824	0.0281	CcSEcCtD
Pomalidomide—Asthenia—Propantheline—pancreatitis	0.000802	0.0274	CcSEcCtD
Pomalidomide—Dizziness—Propantheline—pancreatitis	0.000739	0.0252	CcSEcCtD
Pomalidomide—Vomiting—Propantheline—pancreatitis	0.000711	0.0242	CcSEcCtD
Pomalidomide—Mental disorder—Hyoscyamine—pancreatitis	0.000706	0.0241	CcSEcCtD
Pomalidomide—Rash—Propantheline—pancreatitis	0.000705	0.024	CcSEcCtD
Pomalidomide—Dermatitis—Propantheline—pancreatitis	0.000704	0.024	CcSEcCtD
Pomalidomide—Headache—Propantheline—pancreatitis	0.0007	0.0239	CcSEcCtD
Pomalidomide—Nausea—Propantheline—pancreatitis	0.000664	0.0227	CcSEcCtD
Pomalidomide—Vertigo—Hyoscyamine—pancreatitis	0.00063	0.0215	CcSEcCtD
Pomalidomide—Anxiety—Hyoscyamine—pancreatitis	0.000595	0.0203	CcSEcCtD
Pomalidomide—Confusional state—Hyoscyamine—pancreatitis	0.000577	0.0197	CcSEcCtD
Pomalidomide—Hyperhidrosis—Hyoscyamine—pancreatitis	0.000553	0.0189	CcSEcCtD
Pomalidomide—PTGS2—islet of Langerhans—pancreatitis	0.00054	0.0424	CbGeAlD
Pomalidomide—Insomnia—Hyoscyamine—pancreatitis	0.000518	0.0177	CcSEcCtD
Pomalidomide—Dyspnoea—Hyoscyamine—pancreatitis	0.00051	0.0174	CcSEcCtD
Pomalidomide—Fatigue—Hyoscyamine—pancreatitis	0.000493	0.0168	CcSEcCtD
Pomalidomide—Pain—Hyoscyamine—pancreatitis	0.000489	0.0167	CcSEcCtD
Pomalidomide—Constipation—Hyoscyamine—pancreatitis	0.000489	0.0167	CcSEcCtD
Pomalidomide—Feeling abnormal—Hyoscyamine—pancreatitis	0.000472	0.0161	CcSEcCtD
Pomalidomide—Body temperature increased—Hyoscyamine—pancreatitis	0.000452	0.0154	CcSEcCtD
Pomalidomide—Hypersensitivity—Hyoscyamine—pancreatitis	0.000422	0.0144	CcSEcCtD
Pomalidomide—Asthenia—Hyoscyamine—pancreatitis	0.000411	0.014	CcSEcCtD
Pomalidomide—Pruritus—Hyoscyamine—pancreatitis	0.000405	0.0138	CcSEcCtD
Pomalidomide—Diarrhoea—Hyoscyamine—pancreatitis	0.000392	0.0134	CcSEcCtD
Pomalidomide—CYP1A2—digestive system—pancreatitis	0.000391	0.0307	CbGeAlD
Pomalidomide—PTGS2—pancreas—pancreatitis	0.00038	0.0298	CbGeAlD
Pomalidomide—Dizziness—Hyoscyamine—pancreatitis	0.000379	0.0129	CcSEcCtD
Pomalidomide—CYP1A2—blood—pancreatitis	0.000373	0.0293	CbGeAlD
Pomalidomide—Vomiting—Hyoscyamine—pancreatitis	0.000364	0.0124	CcSEcCtD
Pomalidomide—Rash—Hyoscyamine—pancreatitis	0.000361	0.0123	CcSEcCtD
Pomalidomide—Dermatitis—Hyoscyamine—pancreatitis	0.000361	0.0123	CcSEcCtD
Pomalidomide—Headache—Hyoscyamine—pancreatitis	0.000359	0.0122	CcSEcCtD
Pomalidomide—Nausea—Hyoscyamine—pancreatitis	0.00034	0.0116	CcSEcCtD
Pomalidomide—ABCB1—islet of Langerhans—pancreatitis	0.000334	0.0262	CbGeAlD
Pomalidomide—PTGS2—digestive system—pancreatitis	0.000324	0.0255	CbGeAlD
Pomalidomide—PTGS2—blood—pancreatitis	0.000309	0.0243	CbGeAlD
Pomalidomide—CYP3A4—digestive system—pancreatitis	0.000283	0.0222	CbGeAlD
Pomalidomide—CYP3A4—blood—pancreatitis	0.00027	0.0212	CbGeAlD
Pomalidomide—ABCB1—pancreas—pancreatitis	0.000235	0.0184	CbGeAlD
Pomalidomide—ABCB1—digestive system—pancreatitis	0.000201	0.0157	CbGeAlD
Pomalidomide—ABCB1—blood—pancreatitis	0.000191	0.015	CbGeAlD
Pomalidomide—TNF—Allograft Rejection—CXCL8—pancreatitis	0.000183	0.00195	CbGpPWpGaD
Pomalidomide—TNF—Integrated Pancreatic Cancer Pathway—PDGFA—pancreatitis	0.000182	0.00195	CbGpPWpGaD
Pomalidomide—TNF—Cardiac Hypertrophic Response—TGFB1—pancreatitis	0.000182	0.00194	CbGpPWpGaD
Pomalidomide—PTGS2—Spinal Cord Injury—EGR1—pancreatitis	0.000181	0.00194	CbGpPWpGaD
Pomalidomide—CYP1A2—Aryl Hydrocarbon Receptor—LPL—pancreatitis	0.000177	0.00189	CbGpPWpGaD
Pomalidomide—TNF—Allograft Rejection—IL1B—pancreatitis	0.000175	0.00187	CbGpPWpGaD
Pomalidomide—TNF—Alzheimers Disease—IL1B—pancreatitis	0.000175	0.00187	CbGpPWpGaD
Pomalidomide—TNF—Alzheimers Disease—CASP3—pancreatitis	0.000175	0.00187	CbGpPWpGaD
Pomalidomide—TNF—Allograft Rejection—CASP3—pancreatitis	0.000175	0.00187	CbGpPWpGaD
Pomalidomide—TNF—Selenium Micronutrient Network—PTGS2—pancreatitis	0.000173	0.00185	CbGpPWpGaD
Pomalidomide—TNF—SIDS Susceptibility Pathways—HTR2A—pancreatitis	0.000171	0.00183	CbGpPWpGaD
Pomalidomide—TNF—Regulation of toll-like receptor signaling pathway—TLR4—pancreatitis	0.000171	0.00183	CbGpPWpGaD
Pomalidomide—TNF—TWEAK Signaling Pathway—IL6—pancreatitis	0.00017	0.00182	CbGpPWpGaD
Pomalidomide—TNF—Downstream signaling in naïve CD8+ T cells—NRAS—pancreatitis	0.000169	0.00181	CbGpPWpGaD
Pomalidomide—TNF—Spinal Cord Injury—CCL2—pancreatitis	0.000168	0.00179	CbGpPWpGaD
Pomalidomide—TNF—Apoptosis—CASP3—pancreatitis	0.000166	0.00178	CbGpPWpGaD
Pomalidomide—ABCB1—Allograft Rejection—HLA-DQA1—pancreatitis	0.000166	0.00177	CbGpPWpGaD
Pomalidomide—TNF—Aryl Hydrocarbon Receptor—HRAS—pancreatitis	0.000165	0.00177	CbGpPWpGaD
Pomalidomide—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—pancreatitis	0.000164	0.00176	CbGpPWpGaD
Pomalidomide—CYP3A4—Biological oxidations—FDX1—pancreatitis	0.000164	0.00175	CbGpPWpGaD
Pomalidomide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—pancreatitis	0.000163	0.00174	CbGpPWpGaD
Pomalidomide—TNF—Selenium Micronutrient Network—IL1B—pancreatitis	0.000161	0.00172	CbGpPWpGaD
Pomalidomide—TNF—Adipogenesis—PPARG—pancreatitis	0.000161	0.00172	CbGpPWpGaD
Pomalidomide—PTGS2—Selenium Micronutrient Network—CRP—pancreatitis	0.000159	0.0017	CbGpPWpGaD
Pomalidomide—TNF—Adipogenesis—INS—pancreatitis	0.000158	0.00169	CbGpPWpGaD
Pomalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—SMO—pancreatitis	0.000156	0.00167	CbGpPWpGaD
Pomalidomide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CASP3—pancreatitis	0.000156	0.00167	CbGpPWpGaD
Pomalidomide—TNF—TNF alpha Signaling Pathway—CASP3—pancreatitis	0.000155	0.00165	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—HSP90AB1—pancreatitis	0.000153	0.00163	CbGpPWpGaD
Pomalidomide—CYP3A4—Biological oxidations—ADH4—pancreatitis	0.000152	0.00163	CbGpPWpGaD
Pomalidomide—CYP3A4—Phase 1 - Functionalization of compounds—ALDH2—pancreatitis	0.00015	0.00161	CbGpPWpGaD
Pomalidomide—TNF—Toll-like Receptor Signaling Pathway—CXCL8—pancreatitis	0.000149	0.00159	CbGpPWpGaD
Pomalidomide—CYP1A2—Biological oxidations—ADH1B—pancreatitis	0.000147	0.00157	CbGpPWpGaD
Pomalidomide—PTGS2—Selenium Micronutrient Network—ICAM1—pancreatitis	0.000146	0.00157	CbGpPWpGaD
Pomalidomide—ABCB1—Allograft Rejection—IL10—pancreatitis	0.000146	0.00157	CbGpPWpGaD
Pomalidomide—TNF—Downstream signaling in naïve CD8+ T cells—KRAS—pancreatitis	0.000146	0.00156	CbGpPWpGaD
Pomalidomide—TNF—Vitamin B12 Metabolism—IL6—pancreatitis	0.000146	0.00156	CbGpPWpGaD
Pomalidomide—TNF—TGF-beta Receptor Signaling—HRAS—pancreatitis	0.000145	0.00155	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism of lipids and lipoproteins—FDX1—pancreatitis	0.000144	0.00154	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—HSP90AB1—pancreatitis	0.000143	0.00153	CbGpPWpGaD
Pomalidomide—TNF—Toll-like Receptor Signaling Pathway—IL1B—pancreatitis	0.000143	0.00153	CbGpPWpGaD
Pomalidomide—PTGS2—Aryl Hydrocarbon Receptor—NRAS—pancreatitis	0.00014	0.00149	CbGpPWpGaD
Pomalidomide—ABCB1—HIF-1-alpha transcription factor network—LEP—pancreatitis	0.000139	0.00149	CbGpPWpGaD
Pomalidomide—TNF—Transcriptional regulation of white adipocyte differentiation—TGFB1—pancreatitis	0.000139	0.00149	CbGpPWpGaD
Pomalidomide—TNF—Spinal Cord Injury—PTGS2—pancreatitis	0.000137	0.00146	CbGpPWpGaD
Pomalidomide—TNF—Allograft Rejection—TGFB1—pancreatitis	0.000136	0.00146	CbGpPWpGaD
Pomalidomide—PTGS2—Selenium Micronutrient Network—INS—pancreatitis	0.000133	0.00142	CbGpPWpGaD
Pomalidomide—TNF—Spinal Cord Injury—CXCL8—pancreatitis	0.000132	0.00142	CbGpPWpGaD
Pomalidomide—PTGS2—Selenium Micronutrient Network—CCL2—pancreatitis	0.000131	0.0014	CbGpPWpGaD
Pomalidomide—TNF—TNF alpha Signaling Pathway—NRAS—pancreatitis	0.00013	0.00139	CbGpPWpGaD
Pomalidomide—TNF—MicroRNAs in cardiomyocyte hypertrophy—TGFB1—pancreatitis	0.00013	0.00139	CbGpPWpGaD
Pomalidomide—TNF—Spinal Cord Injury—IL1B—pancreatitis	0.000127	0.00136	CbGpPWpGaD
Pomalidomide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—pancreatitis	0.000127	0.00136	CbGpPWpGaD
Pomalidomide—TNF—Spinal Cord Injury—CASP3—pancreatitis	0.000127	0.00136	CbGpPWpGaD
Pomalidomide—TNF—Downstream signaling in naïve CD8+ T cells—HRAS—pancreatitis	0.000124	0.00132	CbGpPWpGaD
Pomalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—EGR1—pancreatitis	0.000123	0.00132	CbGpPWpGaD
Pomalidomide—PTGS2—Spinal Cord Injury—LEP—pancreatitis	0.000123	0.00132	CbGpPWpGaD
Pomalidomide—PTGS2—Selenium Micronutrient Network—ALB—pancreatitis	0.000122	0.00131	CbGpPWpGaD
Pomalidomide—PTGS2—Aryl Hydrocarbon Receptor—TNF—pancreatitis	0.000121	0.0013	CbGpPWpGaD
Pomalidomide—PTGS2—Spinal Cord Injury—TLR4—pancreatitis	0.000121	0.00129	CbGpPWpGaD
Pomalidomide—PTGS2—Aryl Hydrocarbon Receptor—KRAS—pancreatitis	0.00012	0.00129	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism of lipids and lipoproteins—PNLIP—pancreatitis	0.000119	0.00127	CbGpPWpGaD
Pomalidomide—TNF—Folate Metabolism—IL6—pancreatitis	0.000118	0.00127	CbGpPWpGaD
Pomalidomide—ABCB1—Allograft Rejection—HLA-DRB1—pancreatitis	0.000118	0.00126	CbGpPWpGaD
Pomalidomide—TNF—Regulation of toll-like receptor signaling pathway—CXCL8—pancreatitis	0.000116	0.00124	CbGpPWpGaD
Pomalidomide—PTGS2—Spinal Cord Injury—ICAM1—pancreatitis	0.000116	0.00124	CbGpPWpGaD
Pomalidomide—CYP3A4—Biological oxidations—ADH1B—pancreatitis	0.000113	0.00121	CbGpPWpGaD
Pomalidomide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—pancreatitis	0.000113	0.00121	CbGpPWpGaD
Pomalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—PDGFA—pancreatitis	0.000113	0.0012	CbGpPWpGaD
Pomalidomide—TNF—TNF alpha Signaling Pathway—KRAS—pancreatitis	0.000112	0.00119	CbGpPWpGaD
Pomalidomide—TNF—Regulation of toll-like receptor signaling pathway—IL1B—pancreatitis	0.000111	0.00119	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—pancreatitis	0.000111	0.00119	CbGpPWpGaD
Pomalidomide—ABCB1—Transmembrane transport of small molecules—CFTR—pancreatitis	0.000106	0.00113	CbGpPWpGaD
Pomalidomide—TNF—SIDS Susceptibility Pathways—CXCL8—pancreatitis	0.000106	0.00113	CbGpPWpGaD
Pomalidomide—CYP1A2—Tryptophan metabolism—MDM2—pancreatitis	0.000105	0.00113	CbGpPWpGaD
Pomalidomide—PTGS2—Spinal Cord Injury—CCL2—pancreatitis	0.000104	0.00111	CbGpPWpGaD
Pomalidomide—CYP1A2—Biological oxidations—ALDH2—pancreatitis	0.000104	0.00111	CbGpPWpGaD
Pomalidomide—PTGS2—Aryl Hydrocarbon Receptor—HRAS—pancreatitis	0.000102	0.00109	CbGpPWpGaD
Pomalidomide—TNF—Apoptosis—CASP3—pancreatitis	0.000102	0.00109	CbGpPWpGaD
Pomalidomide—TNF—SIDS Susceptibility Pathways—IL1B—pancreatitis	0.000102	0.00109	CbGpPWpGaD
Pomalidomide—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—pancreatitis	0.000102	0.00109	CbGpPWpGaD
Pomalidomide—TNF—SIDS Susceptibility Pathways—CASP3—pancreatitis	0.000101	0.00108	CbGpPWpGaD
Pomalidomide—PTGS2—Selenium Micronutrient Network—IL1B—pancreatitis	9.94e-05	0.00106	CbGpPWpGaD
Pomalidomide—TNF—Spinal Cord Injury—TGFB1—pancreatitis	9.87e-05	0.00106	CbGpPWpGaD
Pomalidomide—TNF—Integrated Pancreatic Cancer Pathway—MDM2—pancreatitis	9.64e-05	0.00103	CbGpPWpGaD
Pomalidomide—TNF—MAPK Signaling Pathway—IL1B—pancreatitis	9.58e-05	0.00102	CbGpPWpGaD
Pomalidomide—TNF—MAPK Signaling Pathway—CASP3—pancreatitis	9.56e-05	0.00102	CbGpPWpGaD
Pomalidomide—CYP1A2—Arachidonic acid metabolism—PTGS2—pancreatitis	9.5e-05	0.00102	CbGpPWpGaD
Pomalidomide—TNF—TNF alpha Signaling Pathway—HRAS—pancreatitis	9.49e-05	0.00101	CbGpPWpGaD
Pomalidomide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—pancreatitis	9.45e-05	0.00101	CbGpPWpGaD
Pomalidomide—TNF—Selenium Micronutrient Network—IL6—pancreatitis	9.41e-05	0.00101	CbGpPWpGaD
Pomalidomide—TNF—Integrated Pancreatic Cancer Pathway—PTGS2—pancreatitis	9.29e-05	0.000993	CbGpPWpGaD
Pomalidomide—TNF—Adipogenesis—TGFB1—pancreatitis	9.14e-05	0.000977	CbGpPWpGaD
Pomalidomide—TNF—TNF alpha Signaling Pathway—IL6—pancreatitis	9.08e-05	0.000971	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—CTRB2—pancreatitis	8.82e-05	0.000943	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—EGR1—pancreatitis	8.75e-05	0.000936	CbGpPWpGaD
Pomalidomide—PTGS2—C-MYB transcription factor network—NRAS—pancreatitis	8.62e-05	0.000922	CbGpPWpGaD
Pomalidomide—TNF—Integrated Pancreatic Cancer Pathway—CASP3—pancreatitis	8.62e-05	0.000922	CbGpPWpGaD
Pomalidomide—TNF—Toll-like Receptor Signaling Pathway—IL6—pancreatitis	8.36e-05	0.000894	CbGpPWpGaD
Pomalidomide—PTGS2—Spinal Cord Injury—CXCL8—pancreatitis	8.19e-05	0.000876	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—FDX1—pancreatitis	8.14e-05	0.00087	CbGpPWpGaD
Pomalidomide—CYP3A4—Tryptophan metabolism—MDM2—pancreatitis	8.13e-05	0.000869	CbGpPWpGaD
Pomalidomide—TNF—MAPK Signaling Pathway—NRAS—pancreatitis	8.01e-05	0.000857	CbGpPWpGaD
Pomalidomide—ABCB1—Allograft Rejection—CXCL8—pancreatitis	8e-05	0.000856	CbGpPWpGaD
Pomalidomide—CYP3A4—Biological oxidations—ALDH2—pancreatitis	7.99e-05	0.000854	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFA—pancreatitis	7.98e-05	0.000853	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism of lipids and lipoproteins—PLA2G1B—pancreatitis	7.95e-05	0.00085	CbGpPWpGaD
Pomalidomide—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—pancreatitis	7.9e-05	0.000845	CbGpPWpGaD
Pomalidomide—PTGS2—Spinal Cord Injury—IL1B—pancreatitis	7.86e-05	0.00084	CbGpPWpGaD
Pomalidomide—PTGS2—Spinal Cord Injury—CASP3—pancreatitis	7.84e-05	0.000838	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism of lipids and lipoproteins—A2M—pancreatitis	7.68e-05	0.000821	CbGpPWpGaD
Pomalidomide—ABCB1—Allograft Rejection—IL1B—pancreatitis	7.68e-05	0.000821	CbGpPWpGaD
Pomalidomide—ABCB1—Allograft Rejection—CASP3—pancreatitis	7.66e-05	0.000819	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—LPL—pancreatitis	7.56e-05	0.000809	CbGpPWpGaD
Pomalidomide—TNF—MAPK Signaling Pathway—TGFB1—pancreatitis	7.44e-05	0.000796	CbGpPWpGaD
Pomalidomide—TNF—Spinal Cord Injury—IL6—pancreatitis	7.44e-05	0.000796	CbGpPWpGaD
Pomalidomide—PTGS2—C-MYB transcription factor network—KRAS—pancreatitis	7.42e-05	0.000794	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—CTRB2—pancreatitis	7.39e-05	0.00079	CbGpPWpGaD
Pomalidomide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—pancreatitis	7.34e-05	0.000785	CbGpPWpGaD
Pomalidomide—PTGS2—Selenium Micronutrient Network—TNF—pancreatitis	7.21e-05	0.000771	CbGpPWpGaD
Pomalidomide—TNF—MAPK Signaling Pathway—KRAS—pancreatitis	6.89e-05	0.000737	CbGpPWpGaD
Pomalidomide—TNF—Adipogenesis—IL6—pancreatitis	6.89e-05	0.000736	CbGpPWpGaD
Pomalidomide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—pancreatitis	6.86e-05	0.000733	CbGpPWpGaD
Pomalidomide—CYP1A2—Aryl Hydrocarbon Receptor—TNF—pancreatitis	6.86e-05	0.000733	CbGpPWpGaD
Pomalidomide—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—pancreatitis	6.8e-05	0.000727	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—PNLIP—pancreatitis	6.74e-05	0.000721	CbGpPWpGaD
Pomalidomide—TNF—Integrated Pancreatic Cancer Pathway—TGFB1—pancreatitis	6.72e-05	0.000718	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—PRSS1—pancreatitis	6.69e-05	0.000715	CbGpPWpGaD
Pomalidomide—TNF—Regulation of toll-like receptor signaling pathway—IL6—pancreatitis	6.53e-05	0.000698	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—FDX1—pancreatitis	6.41e-05	0.000685	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—LEP—pancreatitis	6.34e-05	0.000678	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—PRSS3—pancreatitis	6.34e-05	0.000678	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—PNLIP—pancreatitis	6.34e-05	0.000678	CbGpPWpGaD
Pomalidomide—PTGS2—C-MYB transcription factor network—HRAS—pancreatitis	6.31e-05	0.000675	CbGpPWpGaD
Pomalidomide—ABCB1—Transmembrane transport of small molecules—TRPV1—pancreatitis	6.25e-05	0.000668	CbGpPWpGaD
Pomalidomide—TNF—Integrated Pancreatic Cancer Pathway—KRAS—pancreatitis	6.22e-05	0.000665	CbGpPWpGaD
Pomalidomide—PTGS2—Spinal Cord Injury—TGFB1—pancreatitis	6.11e-05	0.000653	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—MET—pancreatitis	6.08e-05	0.00065	CbGpPWpGaD
Pomalidomide—ABCB1—Allograft Rejection—TGFB1—pancreatitis	5.97e-05	0.000638	CbGpPWpGaD
Pomalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—MDM2—pancreatitis	5.96e-05	0.000637	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—ADH4—pancreatitis	5.96e-05	0.000637	CbGpPWpGaD
Pomalidomide—TNF—SIDS Susceptibility Pathways—IL6—pancreatitis	5.95e-05	0.000636	CbGpPWpGaD
Pomalidomide—PTGS2—Selenium Micronutrient Network—IL6—pancreatitis	5.82e-05	0.000622	CbGpPWpGaD
Pomalidomide—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—pancreatitis	5.78e-05	0.000618	CbGpPWpGaD
Pomalidomide—PTGS2—Spinal Cord Injury—TNF—pancreatitis	5.7e-05	0.00061	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—LTF—pancreatitis	5.68e-05	0.000608	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—PRSS1—pancreatitis	5.6e-05	0.000599	CbGpPWpGaD
Pomalidomide—ABCB1—Allograft Rejection—TNF—pancreatitis	5.57e-05	0.000596	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—PPARG—pancreatitis	5.52e-05	0.00059	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—INS—pancreatitis	5.42e-05	0.000579	CbGpPWpGaD
Pomalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—pancreatitis	5.33e-05	0.00057	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—PRSS3—pancreatitis	5.31e-05	0.000568	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—PNLIP—pancreatitis	5.31e-05	0.000568	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—CTRB2—pancreatitis	5.24e-05	0.00056	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—XDH—pancreatitis	4.76e-05	0.000509	CbGpPWpGaD
Pomalidomide—PTGS2—Spinal Cord Injury—IL6—pancreatitis	4.6e-05	0.000492	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—FDX1—pancreatitis	4.54e-05	0.000486	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G1B—pancreatitis	4.5e-05	0.000481	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—ADH1B—pancreatitis	4.44e-05	0.000475	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—A2M—pancreatitis	4.35e-05	0.000465	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—pancreatitis	4.22e-05	0.000452	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—ADH4—pancreatitis	4.22e-05	0.000451	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—CTRB2—pancreatitis	4.18e-05	0.000447	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism of lipids and lipoproteins—LPL—pancreatitis	4.18e-05	0.000447	CbGpPWpGaD
Pomalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—pancreatitis	4.15e-05	0.000444	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—pancreatitis	4.07e-05	0.000436	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—PRSS1—pancreatitis	3.97e-05	0.000424	CbGpPWpGaD
Pomalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—pancreatitis	3.88e-05	0.000415	CbGpPWpGaD
Pomalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—pancreatitis	3.85e-05	0.000411	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—pancreatitis	3.78e-05	0.000404	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—PNLIP—pancreatitis	3.76e-05	0.000402	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—PRSS3—pancreatitis	3.76e-05	0.000402	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—FGA—pancreatitis	3.74e-05	0.000399	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—FDX1—pancreatitis	3.62e-05	0.000388	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—PLA2G1B—pancreatitis	3.54e-05	0.000379	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—A2M—pancreatitis	3.42e-05	0.000366	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—NRAS—pancreatitis	3.38e-05	0.000361	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—XDH—pancreatitis	3.37e-05	0.000361	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—ADH4—pancreatitis	3.37e-05	0.00036	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—PPP3CA—pancreatitis	3.31e-05	0.000354	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—CTRB2—pancreatitis	3.23e-05	0.000345	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—PRSS1—pancreatitis	3.17e-05	0.000339	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—ADH1B—pancreatitis	3.15e-05	0.000337	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—TGFB1—pancreatitis	3.14e-05	0.000336	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—ALDH2—pancreatitis	3.13e-05	0.000335	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism of lipids and lipoproteins—PPARG—pancreatitis	3.05e-05	0.000326	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—PRSS3—pancreatitis	3e-05	0.000321	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—PNLIP—pancreatitis	3e-05	0.000321	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—pancreatitis	2.94e-05	0.000315	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—KRAS—pancreatitis	2.91e-05	0.000311	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—FDX1—pancreatitis	2.8e-05	0.000299	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—pancreatitis	2.75e-05	0.000294	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism of lipids and lipoproteins—ALB—pancreatitis	2.74e-05	0.000293	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—pancreatitis	2.73e-05	0.000292	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—XDH—pancreatitis	2.69e-05	0.000288	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—ADH4—pancreatitis	2.6e-05	0.000278	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—ADH1B—pancreatitis	2.51e-05	0.000269	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—PLA2G1B—pancreatitis	2.51e-05	0.000268	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—PDGFA—pancreatitis	2.5e-05	0.000267	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—HRAS—pancreatitis	2.47e-05	0.000264	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—PRSS1—pancreatitis	2.45e-05	0.000261	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—A2M—pancreatitis	2.42e-05	0.000259	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—GCG—pancreatitis	2.37e-05	0.000254	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—IL6—pancreatitis	2.37e-05	0.000253	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—LPL—pancreatitis	2.36e-05	0.000253	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—PRSS3—pancreatitis	2.32e-05	0.000248	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—PNLIP—pancreatitis	2.32e-05	0.000248	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—LPL—pancreatitis	2.22e-05	0.000238	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—ALDH2—pancreatitis	2.22e-05	0.000237	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—XDH—pancreatitis	2.08e-05	0.000222	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—PLA2G1B—pancreatitis	2e-05	0.000214	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—ADH1B—pancreatitis	1.94e-05	0.000207	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—A2M—pancreatitis	1.94e-05	0.000207	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—LPL—pancreatitis	1.86e-05	0.000199	CbGpPWpGaD
Pomalidomide—ABCB1—Transmembrane transport of small molecules—ALB—pancreatitis	1.85e-05	0.000198	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—ALDH2—pancreatitis	1.77e-05	0.000189	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—pancreatitis	1.73e-05	0.000185	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—GCG—pancreatitis	1.68e-05	0.00018	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—INS—pancreatitis	1.59e-05	0.00017	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—ALB—pancreatitis	1.55e-05	0.000166	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—PLA2G1B—pancreatitis	1.55e-05	0.000165	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—A2M—pancreatitis	1.49e-05	0.00016	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—ALDH2—pancreatitis	1.37e-05	0.000146	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—PPARG—pancreatitis	1.36e-05	0.000145	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—pancreatitis	1.36e-05	0.000145	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—GCG—pancreatitis	1.34e-05	0.000143	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—INS—pancreatitis	1.33e-05	0.000142	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—MDM2—pancreatitis	1.32e-05	0.000142	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—LPL—pancreatitis	1.32e-05	0.000141	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—ALB—pancreatitis	1.22e-05	0.000131	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—LPL—pancreatitis	1.05e-05	0.000113	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—GCG—pancreatitis	1.04e-05	0.000111	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—NRAS—pancreatitis	9.93e-06	0.000106	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—PPARG—pancreatitis	9.63e-06	0.000103	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—INS—pancreatitis	9.44e-06	0.000101	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—TGFB1—pancreatitis	9.22e-06	9.86e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—ALB—pancreatitis	8.66e-06	9.26e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—KRAS—pancreatitis	8.54e-06	9.14e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—LPL—pancreatitis	8.12e-06	8.69e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—PPARG—pancreatitis	7.69e-06	8.22e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—PTGS2—pancreatitis	7.57e-06	8.1e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—INS—pancreatitis	7.54e-06	8.06e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—HRAS—pancreatitis	7.26e-06	7.77e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—IL6—pancreatitis	6.95e-06	7.43e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—ALB—pancreatitis	6.91e-06	7.39e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—PTGS2—pancreatitis	6.05e-06	6.47e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—PPARG—pancreatitis	5.93e-06	6.34e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—INS—pancreatitis	5.82e-06	6.22e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—ALB—pancreatitis	5.33e-06	5.7e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—PTGS2—pancreatitis	4.67e-06	4.99e-05	CbGpPWpGaD
